The in vitro bioavailability of anti‐platelet peptides in collagen hydrolysate from silver carp ( Hypophthalmichthys molitrix ) skin
Authors:
- 8 April 2020
- journal article
- research article
- Published by Wiley in Journal of Food Biochemistry
- Vol. 44 (6) , e13226
Abstract
Previous animal experiments indicated collagen hydrolysates (CHs) intake decreased platelet release indicators in plasma and highlight potential applications as healthcare supplements to combat cardiovascular disease. The oligopeptides (GPR, GPRG, and GPRGP) have anti‐platelet activities. However, it is still unclear whether they are bioactive compounds in CHs from silver carp skin. We investigated the bioavailability of oligopeptides using simulated gastrointestinal digestion and Caco‐2 model. Anti‐thrombotic activities, in vitro platelet aggregation and formation of platelet thrombus, were evaluated. They resisted gastrointestinal digestion and could be absorbed by Caco‐2. Oligopeptides inhibited platelet aggregation induced by adenosine diphosphate and thrombin with IC50 of 0.160, 0.283, 0.251 mg/ml and 0.714, 1.008, 0.917 mg/ml for GPR, GPRG, and GPRGP, respectively. Oligopeptides prolonged the time of platelet thrombus and inhibited coagulation cascades, but CHs performed no bleeding side effect. These results confirmed that oligopeptides could be used as bioactive compounds of dietary supplements for pre‐thrombotic to prevent thrombosis. Practical applications Oligopeptides, GPR, GPRG, and GPRGP, derived from silver carp (Hypophthalmichthys molitrix) skin collagen, performed anti‐thrombotic activities from their anti‐platelet aggregation and anticoagulation activities. But the collagen hydrolysates containing these peptides had no side effect of bleeding in the mice model. Furthermore, this study investigated the bioavailability of these three bioactive peptides by the Caco‐2 cells model. Thus, oligopeptides GPR, GPRG, and GPRGP are a potential index of bioactive compounds in the preparation of anti‐thrombotic functional foods or healthcare supplements for people at the pre‐thrombotic state.Keywords
Funding Information
- China Agriculture Research System (CARS-46)
This publication has 48 references indexed in Scilit:
- New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylationEuropean Journal of Pharmaceutical Sciences, 2012
- Insulin, Insulin Resistance, and Platelet Signaling in DiabetesDiabetes Care, 2009
- Enfermedad aterotrombótica coronaria: avances en el tratamiento antiplaquetarioRevista Espanola de Cardiologia, 2008
- Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMPBritish Journal of Haematology, 2007
- Minidose Aspirin and Gastrointestinal Bleeding—A Retrospective, Case–Control Study in Hospitalized PatientsDigestive Diseases and Sciences, 2005
- A novel anticoagulant purified from fish protein hydrolysate inhibits factor XIIa and platelet aggregationLife Sciences, 2005
- The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristicsCell Biology and Toxicology, 2005
- Does hypertension confer a hypercoagulable state?Journal Of Hypertension, 1998
- Platelet Adhesion to Native Type I Collagen FibrilsJournal of Biological Chemistry, 1998
- Inhibitory effects of enzymatic hydrolysates of collagen and collagen-related synthetic peptides on fibrinogen/thrombin clottingBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1993